학술논문
110P Real-world evaluation of pembrolizumab monotherapy for previously treated PD-L1 positive (TPS>1%) advanced NSCLC in France
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology April 2021 16(4) Supplement:S758-S758
Subject
Language
ISSN
1556-0864